Axcelis Beats Q3 But Stock Still $50 Below Target
Axcelis Technologies delivered its fourth consecutive earnings beat in Q3 with a 13.6% EPS surprise, drawing a Craig Hallum upgrade to Buy. Yet shares trade $99.32, $50 below the $150 consensus target
Axcelis Beats Q3 Estimates But Trades $50 Below Target
NEW YORK, November 6 —
Four consecutive earnings beats at Axcelis Technologies, Inc. (ACLS), including a 13.6% positive EPS surprise in Q3 2026, have failed to close a $50 gap to the $150 analyst consensus price target, with shares at $99.32 even as Craig Hallum upgraded to Buy following the Q3 earnings release.
- Q3 EPS of $1.26 beat the consensus by 13.6%; revenue estimates also topped, per the November 5 8-K
- Trailing revenue $870 million, growing 10.6% year-over-year; gross margin 43.0%; net cash $330 million
- Shares at 18.9x forward earnings, roughly $50 below the $150 analyst consensus target, implying 51% upside
The Beat Is Getting Smaller
Axcelis designs and manufactures ion implantation equipment used in semiconductor fabrication, with a secondary business in aftermarket parts, upgrades, and services for chip manufacturers who buy direct with no distributor in between. The beat streak is consistent but the magnitude is compressing: from a 33.1% EPS upside four quarters ago to 19.0% two quarters later and now 13.6%. A tightening surprise margin can mean the business is maturing, or that analyst models are catching up to management's visibility. With Q4 2026 guidance now issued alongside Q3 results, the next earnings cycle will show which interpretation holds.
What 6.8% Short Interest Signals
If execution alone drove valuation, four straight beats and simultaneous Buy reaffirmations from Craig Hallum and B. Riley would have closed that spread. They have not. Short interest at 6.8% of the float puts a real cohort against the stock despite the analyst consensus, and that position most likely reflects a view on semiconductor equipment cyclicality rather than anything specific to Axcelis's balance sheet, which carries $400 million in cash against $70 million in debt. Free cash flow of $42 million is a positive signal on cash generation, though one that short sellers appear to be discounting in favor of a sector cycle argument.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| ACLS | $3.1B | 18.9x | +5.0% |
| COHU | $1.8B | 15.9x | +45.8% |
| KLIC | $3.3B | 10.8x | +55.7% |
| ENTG | $19.7B | 23.1x | +43.9% |
| PLAB | $1.6B | 13.1x | +17.5% |
| LSCC | $15.0B | 24.0x | +54.4% |
What Forces a Rerating
The specific catalyst is a fifth consecutive beat when Q4 results arrive, which would pressure short sellers and require analysts to reassess a multiple that sits 51% below current consensus. At 18.9x forward earnings, running the implied growth assumptions through a DCF calculator shows how sensitive the valuation is to cycle assumptions. B. Riley's reaffirmation and Craig Hallum's upgrade define the analyst floor; the Q4 guidance already issued sets the bar. Run the free Axcelis Technologies, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Did Axcelis beat Q3 earnings?
Yes. Axcelis reported Q3 EPS of $1.26, beating the $1.106 consensus estimate by 13.6%, and revenue also topped expectations. This is the company's fourth consecutive beat, though the margin is narrowing from a 33.1% EPS surprise four quarters ago to 13.6% this quarter.
What does Axcelis Technologies make?
Axcelis designs and manufactures ion implantation equipment used in semiconductor fabrication. The company also provides aftermarket parts, upgrades, and services directly to chip manufacturers without using distributors.
What is the analyst price target for Axcelis?
Wall Street's consensus price target is $150 per share, implying 51% upside from the current $99.32 trading level. A Craig Hallum upgrade to Buy followed the Q3 earnings release, yet the $50 gap to consensus persists.
Why do short sellers have a 6.8% position in Axcelis?
The short interest likely reflects a sector view on semiconductor equipment cyclicality rather than company-specific weakness. Axcelis's balance sheet is solid with $400 million in cash against $70 million in debt and $42 million in free cash flow generation.
Axcelis Technologies reported a Q3 2026 earnings beat on November 5 — its fourth consecutive quarter topping Wall Street estimates — yet shares remain near $99, roughly $50 below the $150 analyst consensus price target. Two analysts reaffirmed or upgraded Buy ratings the same day, sharpening the question of what will finally close the gap.